Skip to main content

Autoimmune Diseases Linked to Digestive System Cancers

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 15, 2025.

via HealthDay

FRIDAY, Aug. 15, 2025 -- Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of eClinicalMedicine.

Julia Reizner, from the University of Augsburg in Germany, and colleagues conducted a systematic review to examine the associations between celiac disease (CD), systemic lupus erythematosus (SLE), multiple sclerosis (MS), and type 1 diabetes (T1D) and different digestive system cancers. The primary meta-analytic approach used was inverse-variance weighted random-effects models.

A total of 237 estimates from 47 studies covering more than 1.5 million cases of any ethnicity were included in the study. The researchers identified positive associations for CD, SLE, and T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers. There was also a positive association seen for T1D with stomach and colorectal cancers. The strongest bias-corrected association was found between CD and small intestine cancer (relative risk, 4.19). Inverse associations were seen for MS with pancreatic, esophageal, rectal, and colorectal cancers.

"Our results underline the need for targeted monitoring of patients with autoimmune diseases and the development of personalized cancer prevention programs," Reizner said in a statement. "The study thus provides important impetus for clinical practice and the development of preventive strategies."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes

THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...

Adenoma Detection Rate of Standard Colonoscopy Declines After Exposure to AI-Assisted Colonoscopy

WEDNESDAY, Aug. 13, 2025 -- Exposure to artificial intelligence (AI)-assisted colonoscopy is associated with a reduction in the adenoma detection rate (ADR) by endoscopists...

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

TUESDAY, Aug. 12, 2025 -- For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.